Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies

INTRODUCTION: We report data from adult and pediatric patients with severe sepsis from studies evaluating drotrecogin alfa (activated) (DrotAA) and presenting with purpura fulminans (PF), meningitis (MEN), or meningococcal disease (MD) (PF/MEN/MD). Such conditions may be associated with an increased...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincent, Jean-Louis, Nadel, Simon, Kutsogiannis, Demetrios J, Gibney, RT Noel, Yan, S Betty, Wyss, Virginia L, Bailey, Joan E, Mitchell, Carol L, Sarwat, Samiha, Shinall, Stephen M, Janes, Jonathan M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1269439/
https://www.ncbi.nlm.nih.gov/pubmed/16137345
http://dx.doi.org/10.1186/cc3538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1269439/
https://www.ncbi.nlm.nih.gov/pubmed/16137345
http://dx.doi.org/10.1186/cc3538

Ejemplares similares